Archives

India’s research expertise, its manufacturing capacity, and the important role that India plays in global efforts to end the tuberculosis (TB) epidemic make it an exciting venue to host the 5th [...]

Nature News&Comment 22/07/2017 21:00 Not enough attention has been paid to vaccines in the quest to beat drug-resistant infections: read the editorial  

Researchers at the University of Zaragoza (belonging to CIBERES) and the biopharmaceutical vaccine company Biofabri in Porrino, Spain, in partnership with the TuBerculosis Vaccine Initiative [...]

TBVI is pleased to announce the 3 winners of the young scientist award 2017. Each of these winners are outstanding scientist in the TB vaccine R&D field. TBVI wishes them a very successful [...]

As of 1 of March,  Jelle Thole has joined TBVI full time as Director Product and Clinical Development. His major role will be to lead the Product & Clinical Development Team (P&CDT) of [...]

Unitat de Tuberculosi Experimental is part of a foundation for TB and within it, they have organised an art competition to raise funds. Please find attached the leaflet and check the website at [...]

EDCTP recently published new Calls for Proposals. For tuberculosis vaccine development, in particular the call “Vaccines for poverty-related diseases” is of interest to TB vaccine R&D [...]

The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship in Systems Immunology to conduct research on a newly funded project aimed at identifying [...]

TuBerculosis Vaccine Initiative (www.tbvi.eu), a unique product development partnership (PDP) in the field of TB vaccine R&D, is recruiting an early to mid-career dynamic person for the [...]

The Norwegian Agency for Development Cooperation (Norad) has commissioned the Norwegian Institute of Public Health (NIPH) to conduct a review of the Norwegian Ministry of Foreign Affairs [...]